Co-reporter:Yi Li;Gang Guo;Li Li;Fei Chen;Ji Bao;Yu-jun Shi
Cell and Tissue Research 2015 Volume 360( Issue 2) pp:297-307
Publication Date(Web):2015 May
DOI:10.1007/s00441-014-2055-x
Mesenchymal stem cell (MSC) transplantation is a promising treatment of many diseases. However, conventional techniques with cells being cultured as a monolayer result in slow cell proliferation and insufficient yield to meet clinical demands. Three-dimensional (3D) culture systems are gaining attention with regard to recreating a complex microenvironment and to understanding the conditions experienced by cells. Our aim is to establish a novel 3D system for the culture of human umbilical cord MSCs (hUC-MSCs) within a real 3D microenvironment but with no digestion or passaging. Primary hUC-MSCs were isolated and grown in serum-free medium (SFM) on a suspension Rocker system. Cell characteristics including proliferation, phenotype and multipotency were recorded. The therapeutic effects of 3D-cultured hUC-MSCs on carbon tetrachloride (CCl4)-induced acute liver failure in mouse models were examined. In the 3D Rocker system, hUC-MSCs formed spheroids in SFM and maintained high viability and active proliferation. Compared with monolayer culture, the 3D-culture system yielded more hUC-MSCs cells within the same volume. The spheroids expressed higher levels of stem cell markers and displayed stronger multipotency. After transplantation into mouse, 3D hUC-MSCs significantly promoted the secretion of interferon-γ and interleukin-6 but inhibited that of tumor necrosis factor-α, thereby alleviating liver necrosis and promoting regeneration following CCl4 injury. The 3D culture of hUC-MSCs thus promotes cell yield and stemness maintenance and represents a promising strategy for hUC-MSCs expansion on an industrial scale with great potential for cell therapy and biotechnology.
Co-reporter:Lijia Cheng, Yujun Shi, Feng Ye, Hong Bu
Materials Science and Engineering: C 2013 Volume 33(Issue 3) pp:1254-1260
Publication Date(Web):1 April 2013
DOI:10.1016/j.msec.2012.12.023
Although osteoinduction mechanism of calcium phosphate (CP) ceramics is still unclear, several essential properties have been reported, such as chemical composition, pore size and porosity, etc. In this study, calcium phosphate powder (Ca3(PO4)2, CaP, group 1), biphasic calcium phosphate ceramic powder (BCP, group 2), and intact BCP rods (group 3) were implanted into leg muscles of mice and dorsal muscles of rabbits. One month and three months after implantation, samples were harvested for biological and histological analysis. New bone tissues were observed in 10/10 samples in group 1, 3/10 samples in group 2, and 9/10 samples in group 3 at 3rd month in mice, but not in rabbits. In vitro, human mesenchymal stem cells (hMSCs) were cultured with trace CaP and BCP powder, and osteogenic differentiation was observed at day 7. Our results suggested that chemical composition is the prerequisite in osteoinduction, and pore structure would contribute to more bone formation.Highlights► Intrinsic osteoinduction of calcium phosphate biomaterials was observed implanted in muscles of mice. ► Biomaterials powder also has osteoinduction property. ► Osteogenic genes and protein could be detected by RT-PCR and Western blot in implanted biomaterials. ► Osteogenic phenomenon could be observed by electron microscopy. ► The chemical composition is the prerequisite in osteoinduction, and pore structure would contribute to more bone formation.
Co-reporter:Lijia Cheng, Xin Duan, Zhou Xiang, Yujun Shi, Xiaofeng Lu, Feng Ye, Hong Bu
Applied Surface Science 2012 Volume 262() pp:200-206
Publication Date(Web):1 December 2012
DOI:10.1016/j.apsusc.2012.04.168
Abstract
Many studies have shown that calcium phosphate ceramics (CP) have osteoconductive and osteoinductive properties; however, the exact mechanism of bone induction has not yet been reported. This study was performed to investigate if destroying immunological function will influence osteogenesis, to explain the mechanism which is unclear. In this study, twenty C57BL/6 mice were divided into two groups (n = 10), in group 1, a hydroxyapatite/β-tricalcium phosphate (HA/β-TCP) ceramic was implanted into both the left and right leg muscles of each mouse; in group 2, ten mice experienced lethal irradiation, then were injected bone marrow (BM) cells from green fluorescent protein (GFP) transgenic mice by tail veil, after bone marrow transplantation (BMT), heart, liver, spleen, lung, kidney, and muscle were harvested for biological analysis, after the GFP chimera model was established successfully, the same HA/β-TCP ceramic was implanted into both leg muscles of each mouse immediately after irradiation. 45 and 90 days after implantation, the ceramics of the two groups were harvested to perform with hematoxylin and eosin (HE) and immunohistochemistry (IHC) staining; the results showed that there was no bone formation in group 2, while new bone tissues were detected in group 1. Our findings suggest that the BM cell from GFP transgenic mice is a good biomarker and it could set a good platform for chimera model; it also shows that BM cell is one of cell resources of bone induction, and destruction of immune function will impede osteoinduction by CP. Overall, our results may shed light on clear mechanism study of bone induction in the future.
Co-reporter:Lijia Cheng, Xiaofeng Lu, Yujun Shi, Li Li, Jing Xue, Li Zhang, Jie Xia, Yujia Wang, Xingdong Zhang, Hong Bu
Applied Surface Science 2012 Volume 262() pp:188-193
Publication Date(Web):1 December 2012
DOI:10.1016/j.apsusc.2012.04.122
Abstract
Bone tissue engineering (BTE) is approached via implantation of autogenous mesenchymal stem cells (MSCs), marrow cells, or platelet-rich plasma, etc. To the contrary, gene therapy combining with the bone marrow (BM) has not been often reported. This study was performed to investigate whether a modified BTE method, that is, the BM and a recombinant human bone morphogenetic protein-2 adenovirus (Ad.hBMP-2) gene administering in hydroxyapatite/β-tricalcium phosphate (HA/β-TCP) ceramics could accelerate the healing of segmental defects in the rabbit radius. In our study, ceramics were immersed in the adenovirus overnight, and half an hour before surgery, autologous BM aspirates were thoroughly mixed with the ceramics; at the same time, a 15-mm radius defect was introduced in the bilateral forelimbs of all animals, after that, this defect was filled with the following: (1) Ad.hBMP-2 + HA/β-TCP + autologous BM (group 1); (2) HA/β-TCP + Ad.hBMP-2 (group 2); (3) HA/β-TCP alone (group 3); (4) an empty defect as a control (group 4). Histological observation and μ-CT analyses were performed on the specimens at weeks 2, 4, 8, and 12, respectively. In group 1, new bone was observed at week 4 and BM appeared at week 12, in groups 2 and 3, new bone was observed at week 8 and it was more mature at week 12, in contrast, the defect was not bridged in group 4 at week 12. The new bone area percentage in group 1 was significantly higher than that in groups 2 and 3. Our study indicated that BM combined with hBMP-2 adenovirus and porous ceramics could significantly increase the amount of newly formed bone. And this modified BTE method thus might have potentials in future clinical application.
Co-reporter:Qi Ke;Rui-na Yang;Feng Ye;Yu-jia Wang
Journal of Zhejiang University-SCIENCE B 2012 Volume 13( Issue 9) pp:695-706
Publication Date(Web):2012 September
DOI:10.1631/jzus.B1100362
Background and objective: Liver regeneration is a complex process regulated by a group of genetic and epigenetic factors. A variety of genetic factors have been reported, whereas few investigations have focused on epigenetic regulation during liver regeneration. In the present study, valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, was used to investigate the effect of HDAC on liver regeneration. Methods: VPA was administered via intraperitoneal injection to 2/3 partially hepatectomized mice to detect hepatocyte proliferation during liver regeneration. The mice were sacrificed, and their liver tissues were harvested at sequential time points from 0 to 168 h after treatment. DNA synthesis was detected via a BrdU assay, and cell proliferation was tested using Ki-67. The expressions of cyclin D1, cyclin E, cyclin dependent kinase 2 (CDK2), and CDK4 were detected by Western blot analysis. Chromatin immunoprecipitation (ChIP) assay was used to examine the recruitment of HDACs to the target promoter regions and the expression of the target gene was detected by Western blot. Results: Immunohistochemical analysis showed that cells positive for BrdU and Ki-67 decreased, and the peak of BrdU was delayed in the VPA-administered mice. Consistently, cyclin D1 expression was also delayed. We identified B-myc as a target gene of HDACs by complementary DNA (cDNA) microarray. The expression of B-myc increased in the VPA-administered mice after hepatectomy (PH). The ChIP assay confirmed the presence of HDACs at the B-myc promoter. Conclusions: HDAC activities are essential for liver regeneration. Inhibiting HDAC activities delays liver regeneration and induces liver cell cycle arrest, thereby causing an anti-proliferative effect on liver regeneration.
Co-reporter:Rui-na Yang;Feng Ye;Li-jia Cheng
Journal of Zhejiang University-SCIENCE B 2011 Volume 12( Issue 7) pp:582-590
Publication Date(Web):2011 July
DOI:10.1631/jzus.B1000204
The osteoinduction of porous biphasic calcium phosphate ceramics (BCP) has been widely reported and documented, but little research has been performed on rodent animals, e.g., mice. In this study, we report osteoinduction in a mouse model. Thirty mice were divided into two groups. BCP materials (Sample A) and control ceramics (Sample B) were implanted into the leg muscle, respectively. Five mice in each group were killed at 15, 30, and 45 d after surgery. Sample A and Sample B were harvested and used for hematoxylin and eosin (HE) staining, immunohistochemistry (IHC) staining, and Alizarin Red S staining to check bone formation in the biomaterials. Histological analysis showed that no bone tissue was formed 15 d after implantation (0/5) in either of the two groups. Newly-formed bone tissues were observed in Sample A at 30 d (5/5) and 45 d (5/5) after implantation; the average amounts of newly-formed bone tissues were approximately 5.2% and 8.6%, respectively. However, we did not see any bone tissue in Sample B until 45 d after implantation. Bone-related molecular makers such as bone morphogenesis protein-2 (BMP-2), collagen type I, and osteopontin were detected by IHC staining in Sample A 30 d after implantation. In addition, the newly-formed bone was also confirmed by Alizarin Red S staining. Because this is the report of osteoinduction in the rodent animal on which all the biotechnologies were available, our results may contribute to further mechanism research.
Co-reporter:Lijia Cheng, Feng Ye, Ruina Yang, Xiaofeng Lu, Yujun Shi, Li Li, Hongsong Fan, Hong Bu
Acta Biomaterialia 2010 Volume 6(Issue 4) pp:1569-1574
Publication Date(Web):April 2010
DOI:10.1016/j.actbio.2009.10.050
Abstract
Many studies have shown that calcium phosphate ceramics can induce bone formation in non-osseous sites without the application of any osteoinductive biomolecules, but the mechanisms of this phenomenon (intrinsic osteoinduction of bioceramics) remain unclear. In this study, we compared the intrinsic osteoinduction of porous hydroxyapatite/β-tricalcium phosphate (HA/β-TCP) implanted in mice at different sites. In 30 mice the left fibula was fractured and the right fibula was kept intact. A porous HA/β-TCP cylinder was implanted into both the left (group 1) and right (group 2) leg muscles of each animal. In addition, two HA/β-TCP cylinders were bilaterally implanted into leg subcutaneous pockets (group 3) in each of the remaining 15 mice. New bone formation was studied in the three groups by histology, histomorphometry and immunostaining. In group 1 new bone was observed at week 6 and bone marrow appeared at week 12. In group 2 new bone was observed at week 8 and bone marrow appeared at week 12. The new bone area percentage in group 1 was significantly higher than in group 2 at both weeks 8 and 12. In contrast, group 3 did not show any new bone within the period studied. These differences were explained based on the location of the implants and thus their proximity to the osteogenic environment of fracture healing. The results support the hypothesis that intrinsic osteoinduction by calcium phosphate ceramics is the result of adsorption of osteoinductive substances on the surface.
Co-reporter:Lijia Cheng 程丽佳;Feng Ye;Xiaofeng Lu
Journal of Wuhan University of Technology-Mater. Sci. Ed. 2010 Volume 25( Issue 1) pp:28-31
Publication Date(Web):2010 February
DOI:10.1007/s11595-010-1028-5
HA/TCP and HA rods (ϕ5 mm×10 mm) were made for implantation in New Zealand white rabbit with different condition. Sixty three rabbit were divided into three groups: group 1 (n=18), group 2 (n=27) and group 3 (n=18). In group 1, 10 mm radius was defected, and one HA/TCP rod was implanted in the muscle a distant away from the bone defect area. In group 2, also, 10 mm radius was defected, one HA rod was implanted in the muscle a distant away from the bone defect area. In group 3, two HA/TCP rods were implanted in the dorsal muscle of the rabbit with bone intact. Histological observation showed that in group 1, some new bone was found only two months after implantation (n=2), and obvious immature woven bone could be observed in these bioceramics from the 3rd month on. However, in group 3, bone began to be found 6 months after implantation (n=2). In group 2, we could not find any bone tissue up to 9 month’s observation. These results suggest that, first, the bone defect model could significantly accelerate bone formation at non-osseous sites in rabbits; second,. HA/TCP bioceramics were confirmed with osteoinductive property while HA bioceramics without osteoinductive property nearly. Thus, bone defect might be a good animal model for further researches for osteoinductive bioceramics.
Co-reporter:Jin-jing Wang;Feng Ye;Li-jia Cheng
Journal of Zhejiang University-SCIENCE B 2009 Volume 10( Issue 5) pp:
Publication Date(Web):2009 May
DOI:10.1631/jzus.B0820252
Large segmental bone defect repair remains a clinical and scientific challenge with increasing interest focusing on combining gene transfection with tissue engineering techniques. The aim of this study is to investigate the effect of connective tissue growth factor (CTGF) on the proliferation and osteogenic differentiation of the bone marrow mesenchymal stem cells (MSCs).A CTGF-expressing plasmid (pCTGF) was constructed and transfected into MSCs. Then expressions of bone morphogenesis-related genes, proliferation rate, alkaline phosphatase activity, and mineralization were examined to evaluate the osteogenic potential of the CTGF gene-modified MSCs.Overexpression of CTGF was confirmed in pCTGF-MSCs. pCTGF transfection significantly enhanced the proliferation rates of pCTGF-MSCs (P<0.05). CTGF induced a 7.5-fold increase in cell migration over control (P<0.05). pCTGF transfection enhanced the expression of bone matrix proteins, such as bone sialoprotein, osteocalcin, and collagen type I in MSCs. The levels of alkaline phosphatase (ALP) activities of pCTGF-MSCs at the 1st and 2nd weeks were 4.0- and 3.0-fold higher than those of MSCs cultured in OS-medium, significantly higher than those of mock-MSCs and normal control MSCs (P<0.05). Overexpression of CTGF in MSCs enhanced the capability to form mineralized nodules.Overexpression of CTGF could improve the osteogenic differentiation ability of MSCs, and the CTGF gene-modified MSCs are potential as novel cell resources of bone tissue engineering.
Co-reporter:Y. Wang, F. Ye, Q. Ke, Q. Wu, ... H. Bu
Transplantation Proceedings (March 2013) Volume 45(Issue 2) pp:463-473
Publication Date(Web):1 March 2013
DOI:10.1016/j.transproceed.2012.06.063
BackgroundHepatocytes undergo DNA synthesis shortly after liver damage triggered by partial hepatectomy (PH). This study revealed that the rate of liver damage recovery is gender-dependent. Furthermore, histone deacetylase (HDAC) epigenetic factors were discovered, at least in part, to govern the different liver recovery rates that were observed for male and female mice.Materials and MethodsExperimental mice were divided into the following three groups: wild-type male mice, wild-type female mice, and HDAC1flox/flox HDAC2flox/flox Alb-Cre male mice. The different groups underwent a 2/3 PH surgery and were sacrificed after the PH.ResultsImmunohistochemical analysis showed that the peak of 5-bromo-2′-deoxyuridine and the number of proliferating cell nuclear antigen–positive cells is delayed in female livers relative to male livers. Consistent with these results, the expression of cyclin D1, cyclin-dependent kinase 2 (CDK2) and cyclin-dependent kinase 4 (CDK4) in females is lower than that in males. Western blot analysis examining HDAC1 and HDAC2 expression in the male and female liver showed the same trend as the cyclin products listed above or decreased protein expression in females relative to males. The results of immunohistochemistry and Western blot analysis of the HDAC1flox/flox HDAC2flox/flox Alb-Cre liver are consistent with the interesting phenomenon observed in the female mouse liver. Additionally, the hepatocyte proliferation inhibitor B-myc was evaluated as an HDAC1 and HDAC2 target gene. The mRNA levels of B-myc were increased in the female liver compared with the male liver. A chromatin immunoprecipitation assay showed the HDACs directly occupied the B-myc promoter.ConclusionsThe processes of hepatocyte replication and liver mass reconstruction differed in male and female mice. Female subjects show a significantly delayed or decreased rate in these processes, which could be explained by differences in HDAC regulation.
Co-reporter:Changli Lu, Jie Xia, Yongjie Zhou, Xufeng Lu, ... Yujun Shi
Journal of Hepatology (February 2016) Volume 64(Issue 2) pp:342-351
Publication Date(Web):1 February 2016
DOI:10.1016/j.jhep.2015.08.036
Background & AimsThe stimulatory G protein α subunit (Gsα) activates the cAMP-dependent pathway by stimulating the production of cAMP and participates in diverse cell processes. Aberrant expression of Gsα results in various pathophysiological disorders, including tumorigenesis, but little is known about its role in liver regeneration.MethodsWe generated a hepatocyte-specific Gsα gene knockout mouse to demonstrate the essential role of Gsα in liver regeneration using a mouse model with 70% partial hepatectomy (PH) or an intraperitoneal injection of carbon tetrachloride (CCl4).ResultsGsα inactivation dramatically impaired liver regeneration and blocked proliferating hepatocytes in G1/S transition due to the simultaneous depression of cyclin-dependent kinase 2 (CDK2) and cyclin E1. Loss of Gsα led to a fundamental alteration in gene profiles. Among the altered signaling cascades, the MAPK/Erk pathway, which is downstream of growth factor signaling, was disrupted secondary to a defect in phosphorylated Raf1 (pRaf1), resulting in a deficiency in phosphorylated CREB (pCREB) and CDK2 ablation. The lack of pRaf1 also resulted in a failure to phosphorylate retinoblastoma, which releases and activates E2F1, and a decrease in cyclin E1. Although these factors could be phosphorylated through both Gsα and growth factor signaling, the unique function of Raf1 in the growth factor cascade collapsed in response to the lack of Gsα.ConclusionThe growth factor signaling pathway that promotes hepatocyte proliferation is dependent on Gsα signaling. Loss of Gsα leads to a breakdown of the crosstalk between cAMP and growth factor signaling and dramatically impairs liver regeneration.Download high-res image (162KB)Download full-size image
Co-reporter:Wei Wang, Ping Yu, Peng Zhang, Yujun Shi, Hong Bu, Li Zhang
Virus Research (February 2008) Volume 131(Issue 2) pp:160-169
Publication Date(Web):1 February 2008
DOI:10.1016/j.virusres.2007.09.004
Human cytomegalovirus (HCMV) infection is asymptomatic in common persons and could reactive in immunosuppression groups. HCMV was considered as endothelial cells (EC) tropism and leukocyte tropism. We hypothesized that HCMV will infect other cell types from human which have not been reported yet. The HCMV released from human MRC-5 was inoculated into eight human primary cells and cell lines, including human dermal fibroblasts (HDF), human embryo-chondrocytes (HEC), human embryo-myoblasts (HEM), and human embryo-kidney endothelial cell (HEK-EC), human marrow stromal cell (HMSC). The cell lines were ECV304, Chung liver cell and L02. Several detection methods specific for HCMV, in which PCR for HCMV DNA sequences, immunofluorescence for pp65 antigen, Western-blot for gB protein, as well as cytopathic effect observation were conducted at different time post-infection. The results indicated that four cells in our experiment (HDF, HEM, HEC and HMSC) were HCMV-positive. The occurring time of cytopathic effect was different in these four cells. Our experiment found the new tropism and new reservoirs for HCMV.